Skip to main content
Sudeep Pharma Limited logo

Sudeep Pharma Limited — Investor Relations & Filings

Ticker · SUDEEPPHRM ISIN · INE0QPI01025 LEI · 335800ESH1W57DIPAN45 BSE.NS Manufacturing
Filings indexed 76 across all filing types
Latest filing 2025-12-21 Investor Presentation
Country IN India
Listing BSE.NS SUDEEPPHRM

About Sudeep Pharma Limited

https://www.sudeeppharma.com/

Sudeep Pharma Limited specializes in the manufacturing of mineral-based excipients and active pharmaceutical ingredients (APIs). The company’s core portfolio includes high-purity mineral salts such as Calcium Phosphates, Calcium Carbonate, and Calcium Sulfate, which are utilized as essential components in solid dosage formulations and nutritional supplements. These products function as diluents, binders, and mineral sources across various applications. The organization maintains advanced production facilities compliant with international quality standards, including GMP, USP, EP, and BP. A strategic partnership with JRS Pharma enhances its technical expertise and global supply chain capabilities. Sudeep Pharma focuses on providing high-quality, regulatory-compliant mineral solutions to meet the demands of global markets, emphasizing research, development, and stringent quality control processes.

Recent filings

Filing Released Lang Actions
Submission of Investors Presentation
Investor Presentation Classification · 95% confidence The document is dated December 21, 2025, and is addressed to stock exchanges (NSE and BSE) referencing Regulation 30 of SEBI (LODR) Regulations, which pertains to disclosure obligations. It mentions a Q2FY26 Result Presentation and an Earnings Call scheduled for December 22, 2025, to discuss operational and financial performance for the quarter and half year ended September 30, 2025. The document includes an investor presentation with detailed company overview, financial highlights, business strategy, and market position. The content is consistent with a presentation prepared for investors and analysts to communicate quarterly results and business updates. It is not a full financial report (like an interim or annual report), nor is it a brief earnings release or a regulatory filing. The presence of detailed slides and strategic information confirms it is an Investor Presentation. The document length (15,000 characters) supports that it is a full presentation rather than a short announcement or certification. Therefore, the appropriate classification is Investor Presentation (IP).
2025-12-21 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of an extract of un-audited financial results for the second quarter and six months period ended September 30, 2025. It references Regulation 30 and 47 of SEBI (LODR) Regulations, 2015, which govern disclosure requirements for listed companies. The document states that the un-audited financial results have already been submitted in a letter dated December 19, 2025, and now copies of the extract published in newspapers are being submitted. The document is essentially an announcement of the publication of financial results extracts in newspapers and on the company website, not the full financial report itself. The document length is about 15,000 characters, but the content is primarily a notification of publication rather than the full report. According to the "Menu vs Meal" rule, such a document is classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER). Therefore, the appropriate classification is RPA with high confidence.
2025-12-20 English
we refer to our letter dated 19th December 2025 vide which we have submitted the Un-audited Financial Results (Standalone & Consolidated) of the Company for the second quarter and six months ....
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of an extract of un-audited financial results for the second quarter and six months period ended September 30, 2025. It references Regulation 30 and 47 of SEBI (LODR) Regulations, 2015, which govern disclosure requirements for listed companies. The letter states that the un-audited financial results have already been submitted in a prior letter dated December 19, 2025, and now the company is submitting copies of the extract published in newspapers. The document itself does not contain the full financial results or detailed financial statements but is an announcement about the publication of the extract of the financial results. The document length is about 15,000 characters, but the content is primarily an announcement of publication rather than the report itself. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-12-20 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated December 19, 2025, and contains detailed unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. It includes a Limited Review Report by an independent auditor pursuant to SEBI Listing Regulations, which is typical for interim financial reporting. The document contains comprehensive financial statements such as income statement, balance sheet, and cash flow statement for the interim period. The presence of the Limited Review Report and detailed financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-12-19 English
Submission of Financials as on 30.09.2025
Interim / Quarterly Report Classification · 100% confidence The document is dated December 19, 2025, and contains detailed unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. It includes a Limited Review Report by an independent auditor (B S R and Co) pursuant to SEBI Listing Regulations, which is typical for interim financial reporting. The document contains comprehensive financial statements such as income statement, balance sheet, and cash flow statement for the interim period. The presence of Indian Accounting Standard 34 (Ind AS 34) references confirms it is an interim financial report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2025-12-19 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated December 19, 2025, and contains detailed unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. It includes a Limited Review Report by an independent auditor pursuant to SEBI Listing Regulations, which is typical for interim financial reporting. The document contains comprehensive financial statements such as income statement, balance sheet, and cash flow statement for the interim period. The presence of detailed financial data and auditor's review confirms this is an Interim / Quarterly Report rather than just an announcement or certification. The document length (15,000 characters) and content confirm it is a full interim report, not a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-12-19 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.